CIK 0001498382 · Non-accelerated filer<br>Smaller reporting company
TuHURA Biosciences, Inc./NV
Sign in to watch- Ticker
- HURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 990360497
- Phone
- 813-875-6600
- Business address
- 10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
- Former names
- Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 4 Open-market buy CEO, Director bought 7,500 shares at $1.47 ($11,025)
- 8-K Event Regulation FD disclosure
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 10-K/A Report 10-K/A
- 8-K Event Restatement
- 4 Open-market buy President, CEO bought 3,000 shares at an average $0.80 ($2,396)
- 4 Open-market buy President, CEO bought 4,000 shares at $0.83 ($3,320)
- 10-K Report Annual Report
- 4 Open-market buy Chief Scientific Officer bought 10,000 shares at $0.60 ($6,000)
- 4 Open-market buy President, CEO bought 10,000 shares at $0.60 ($6,000)
- 8-K Event Other events
- 4 Open-market buy Chief Scientific Officer bought 75,000 shares at $0.60 ($45,000)
Page 37 of 47 · 929 filings